Schedule 13G ownership disclosure

OHR PHARMACEUTICAL INC

Security class unavailable · CUSIP: 67778H309

Event date: 2019-07-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
467,600
Percent of class
16.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535384-19-000009
Form type
SC 13G
Filer
Kershner Trading Americas,LLC
CIK
CIK 1535384
Filed
Jul 18, 2019
Reporting period
Jul 10, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub